4
Changes in Ownership
Xilio Therapeutics, Inc. Filed Acc 0001193125-25-297205
Options or other derivatives
- CHIEF MEDICAL OFFICER acquired 850,210 shares (grant or award)
- CHIEF MEDICAL OFFICER returned 225,210 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Luptakova Katarina · CHIEF MEDICAL OFFICER
Table II: Derivative
11 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-11-21 | Grant or award : show line 1 in the form Stock Option (right to buy) | +625,000 | 625,000 | D |
| 2025-11-21 | Returned to the company : show line 2 in the form Stock Option (right to buy) | −44,210 | 0 | D |
| 2025-11-21 | Grant or award : show line 3 in the form Stock Option (right to buy) | +44,210 | 44,210 | D |
| 2025-11-21 | Returned to the company : show line 4 in the form Stock Option (right to buy) | −15,000 | 0 | D |
| 2025-11-21 | Grant or award : show line 5 in the form Stock Option (right to buy) | +15,000 | 15,000 | D |
| 2025-11-21 | Returned to the company : show line 6 in the form Stock Option (right to buy) | −35,000 | 0 | D |
| 2025-11-21 | Grant or award : show line 7 in the form Stock Option (right to buy) | +35,000 | 35,000 | D |
| 2025-11-21 | Returned to the company : show line 8 in the form Stock Option (right to buy) | −25,000 | 0 | D |
Loading xslF345X05/ownership.xml…